⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ARQT

Arcutis Biotherapeutics, Inc.

Healthcare · Biotechnology

31.20USD

-1.0000 (-3.11%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ARQT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 31.20
P/E137.5
Dvd Ind Yld0.0%
P/B17.78
P/S8.5
Curr EV/T12M EBITDA104.0
Mkt Cap (USD)3.9B
Curr EV (USD)3.8B
2)

Per Share Data

EPS T12M0.31
DPS—
Bk Val Per Sh1.76
Rev/Sh3.41
Cash/Sh1.90
Curr Shares Out125.7M
FCF/Sh0.29
3)

Cash Flow Analysis

P/CF99.8
Curr P/FCF100.2
CF/NI1.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales8.5%
Eff Interest Rate12.8%
4)

Growth Potential

Dil EPS 1Y Gr88.8%
Cap 1Y Gr12.7%
BPS 1Y Gr14.3%
R&D To Sales19.6%
Retention Rate100.0%
Rev 1Y Gr91.3%
FCF 1Y Gr94.4%
Assets 1Y Gr24.1%
5)

Profitability

EBITDA-0.1B
EBIT0.0B
Operating Margin7.4%
Pretax Margin—
Net Margin6.1%
ROA6.8%
ROE15.9%
ROC—
Asset Turnover1.10
6)

Structure

Current Ratio2.92
Quick Ratio2.46
Debt/Assets22.3%
Debt/Com Eq49.4%
Net Debt/EBITDA-0.62
Tot Debt/Capital33.1%
Gross Margin91.1%
EBIT/Int Exp2.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.